Serum nesfatin-1 concentrations were significantly found to be lower in the participants with GDM compared to the controls (7.9 ± 2.8 vs. 11.2 ± 7.7 ng/mL, respectively, p = 0.020, Table 1). Here, NUCB2 is linked to gestational diabetes.